학술논문

Exploring novel systemic therapies for pancreatic cancer: a review of emerging anti-PD-1/PD-L1 combination therapy.
Document Type
Article
Source
Neoplasma; 2022, Vol. 69 Issue 5, p995-1007, 13p
Subject
PANCREATIC cancer
CANCER treatment
IMMUNE checkpoint inhibitors
PANCREATIC intraepithelial neoplasia
TUMOR microenvironment
DRUG resistance
Language
ISSN
00282685
Abstract
Copyright of Neoplasma is the property of AEPress s.r.o. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)